ImmuCell Corporation Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price
ImmuCell Corporation (ICCC) had Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price of $2.76 per share as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2025-11-13
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $2.76.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $2.81.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $0.00.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $3.12.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2025-09-30 | $2.76 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $2.81 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $3.12 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $2.02 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $2.89 10-Q · filed 2025-05-14 | |
| 2021-12-31 | $3.36 10-K · filed 2022-03-30 | |
| 2021-09-30 | $3.42 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $3.40 10-Q · filed 2021-08-12 | |
| 2020-12-31 | $3.25 10-K · filed 2022-03-30 | |
| 2017-12-31 | $3.49 10-K · filed 2018-03-29 | |
| 2016-12-31 | $3.21 10-K · filed 2018-03-29 | $6.03 10-K · filed 2017-03-30 |
| 2015-12-31 | $5.35 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |